Anchor Investment Management LLC Buys 3,652 Shares of Danaher Corporation $DHR

Key Points

• Anchor Investment Management LLC significantly increased its stake in Danaher Corporation by 73.7%, owning a total of 8,607 shares valued at approximately $1.76 million.
• Several other institutional investors, including MGO One Seven LLC and Horizon Financial Services LLC, also made substantial increases in their Danaher holdings during the first quarter, indicating a strong interest in the stock.
• Danaher recently announced a quarterly dividend of $0.32 per share, with an annualized yield of 0.7%, reflecting a stable financial position for the conglomerate.

Anchor Investment Management LLC lifted its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 73.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,607 shares of the conglomerate's stock after purchasing an additional 3,652 shares during the quarter. Anchor Investment Management LLC's holdings in Danaher were worth $1,764,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. MGO One Seven LLC grew its holdings in shares of Danaher by 485.7% during the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock valued at $5,145,000 after purchasing an additional 20,813 shares during the last quarter. Asahi Life Asset Management CO. LTD. bought a new stake in Danaher during the 1st quarter worth approximately $539,000. Horizon Financial Services LLC grew its holdings in Danaher by 20,400.0% during the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock worth $1,681,000 after acquiring an additional 8,160 shares during the last quarter. Texas Capital Bank Wealth Management Services Inc grew its holdings in Danaher by 6.1% during the 1st quarter. Texas Capital Bank Wealth Management Services Inc now owns 34,763 shares of the conglomerate's stock worth $7,126,000 after acquiring an additional 2,009 shares during the last quarter. Finally, EFG Asset Management Americas Corp. grew its holdings in Danaher by 13.1% during the 1st quarter. EFG Asset Management Americas Corp. now owns 36,080 shares of the conglomerate's stock worth $7,396,000 after acquiring an additional 4,191 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

DHR has been the topic of a number of research reports. Evercore ISI reduced their target price on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a report on Tuesday, July 8th. Guggenheim reissued a "buy" rating and set a $250.00 target price on shares of Danaher in a report on Wednesday, July 23rd. Robert W. Baird boosted their target price on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a report on Friday, July 18th. UBS Group reduced their target price on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. Finally, Scotiabank raised shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price on the stock in a report on Friday, July 11th. Seventeen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $246.35.

Insider Transactions at Danaher

In related news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company's stock, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.10% of the stock is currently owned by corporate insiders.

Danaher Stock Down 0.8%

Shares of NYSE DHR opened at $192.85 on Thursday. The company has a market capitalization of $138.09 billion, a P/E ratio of 41.03, a price-to-earnings-growth ratio of 2.71 and a beta of 0.75. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The company's 50 day moving average price is $201.62 and its 200-day moving average price is $199.15.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company's revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.7%. Danaher's dividend payout ratio is currently 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.